Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,762 | 114,526 | 133,665 | 156,724 | 181,564 |
| Receivables | 12,531 | 9,251 | 7,208 | 9,324 | 7,712 |
| Inventories | 6,702 | 6,242 | 6,794 | 5,588 | 5,512 |
| Other current assets | 5,452 | 3,225 | 6,253 | 6,103 | 7,473 |
| TOTAL | $130,447 | $133,244 | $153,920 | $177,739 | $202,261 |
| Non-Current Assets | |||||
| PPE Net | 604 | 1,372 | 1,554 | 1,697 | 1,847 |
| Intangibles | 2,986 | 1,530 | 1,574 | 1,618 | 1,663 |
| Other Non-Current Assets | 7,419 | 7,769 | 8,130 | 9,993 | 7,012 |
| TOTAL | $11,009 | $10,671 | $11,258 | $13,308 | $10,522 |
| Total Assets | $141,456 | $143,915 | $165,178 | $191,047 | $212,783 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,175 | 13,723 | 11,291 | 14,661 | 13,552 |
| Accrued Expenses | 13,241 | 17,092 | 17,067 | 12,930 | 12,540 |
| TOTAL | $28,284 | $32,015 | $29,450 | $29,042 | $27,875 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,951 | 4,002 | 4,332 | 4,533 | 4,802 |
| TOTAL | $3,951 | $4,002 | $4,332 | $4,533 | $4,802 |
| Total Liabilities | $32,235 | $36,017 | $33,782 | $33,575 | $32,677 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,678 | 43,668 | 43,720 | 43,718 | 43,714 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -436,043 | -437,200 | -409,674 | -368,543 | -340,475 |
| Other shareholders' equity | 1,331 | 4,702 | 3,104 | 1,682 | 1,371 |
| TOTAL | $109,221 | $107,898 | $131,396 | $157,472 | $180,106 |
| Total Liabilities And Equity | $141,456 | $143,915 | $165,178 | $191,047 | $212,783 |